| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |